PCAT6 and colorectal carcinoma: Immunoblotting and chemoresistance mechanistic studies have suggested that the elevated PCAT6 levels inhibit miR‐204 expression in CRC, promoting HMGA2/PI3K signaling pathway activity and enhancing the chemoresistance of CRC cells to 5‐fluorouracil (FU) (28).